Correlation Between X4 Pharmaceuticals and Senti Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Senti Biosciences, you can compare the effects of market volatilities on X4 Pharmaceuticals and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Senti Biosciences.

Diversification Opportunities for X4 Pharmaceuticals and Senti Biosciences

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between XFOR and Senti is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Senti Biosciences go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Senti Biosciences

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 2.07 times less return on investment than Senti Biosciences. But when comparing it to its historical volatility, X4 Pharmaceuticals is 2.44 times less risky than Senti Biosciences. It trades about 0.03 of its potential returns per unit of risk. Senti Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,670  in Senti Biosciences on October 10, 2024 and sell it today you would lose (1,227) from holding Senti Biosciences or give up 73.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

X4 Pharmaceuticals  vs.  Senti Biosciences

 Performance 
       Timeline  
X4 Pharmaceuticals 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in X4 Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, X4 Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Senti Biosciences 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Senti Biosciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Senti Biosciences demonstrated solid returns over the last few months and may actually be approaching a breakup point.

X4 Pharmaceuticals and Senti Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with X4 Pharmaceuticals and Senti Biosciences

The main advantage of trading using opposite X4 Pharmaceuticals and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.
The idea behind X4 Pharmaceuticals and Senti Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets